Open AccessSUN-LB024 Elevation in Morning Glucose Level May Be a Signal for the Development of Immune Checkpoint Inhibitor (ICPi) Induced Autoimmune Diabetes Insulin
Author(s) -
Amy Zhang,
Le Min,
Fang Wang,
L. L. Chang,
Marie E. McDonnell
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sun-lb024
Subject(s) - medicine , diabetes mellitus , thyroiditis , autoimmune thyroiditis , type 1 diabetes , autoantibody , autoimmune disease , ipilimumab , diabetic ketoacidosis , immune system , gastroenterology , adverse effect , autoimmune diabetes , ketoacidosis , endocrinology , immunology , immunotherapy , antibody , thyroid , disease